Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to the complex biological ecosystem comprising the epithelial linings of the vaginal and intestinal tracts, the specific molecular sites where microbes adhere, and the diverse community of resident and pathogenic microorganisms. The epithelial surface provides a physical barrier and expresses receptors, such as glycoproteins and glycolipids, that serve as docking points for microbial adhesins (Pizarro-Guajardo et al., 2018). In a healthy vaginal state, resident microbiota—primarily Lactobacillus species—maintain an acidic environment and produce inhibitory substances like hydrogen peroxide to prevent the colonization of pathogens (Ravel et al., 2011). Disruption of this balance, or dysbiosis, is a primary driver of diseases such as bacterial vaginosis, vulvovaginal candidiasis, and various gastrointestinal disorders (Borges et al., 2014). Therapeutic strategies targeting this system include the use of antibiotics or antifungals to reduce pathogen load, and probiotics to restore beneficial microbial populations and enhance the host's mucosal immunity (Petrova et al., 2015). Additionally, mucosal adhesives and pH-restoring agents are used to stabilize the environment and prevent pathogen attachment. Understanding this ecosystem is vital for developing treatments that modulate the microbiome to improve host health and prevent recurrent infections.
Competitive exclusion of pathogens, production of antimicrobial metabolites (e.g., lactic acid), and modulation of host epithelial barrier function and immune signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal and intestinal microbiota and epithelial adhesion sites.